[Skip to Navigation]
Health Policy
June 20, 2019

Pharmacy Benefit Manager Reform: Lessons From Ohio

Author Affiliations
  • 1University of North Carolina at Chapel Hill School of Medicine
  • 2Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • 3Questrom School of Business, Boston University, Boston, Massachusetts
JAMA. 2019;322(4):299-300. doi:10.1001/jama.2019.7104

Addressing soaring prescription drug prices is a health care reform priority in the United States.1 While the pricing practices of pharmaceutical companies have been a subject of intense scrutiny and reform proposals, so have the practices of pharmacy benefit managers (PBMs), who are intermediaries in the drug supply chain.2

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words